<DOC>
	<DOCNO>NCT02301169</DOCNO>
	<brief_summary>The purpose clinical trial conduct patient suffer chronic pain study relationship individual patient ' profile analgesic response .</brief_summary>
	<brief_title>A Study Investigate Effects New Treatment Patients With Chronic Pain</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<criteria>Men woman least 18 year age Body weight 40 kg less 120 kg BMI 1931 kg/m2 inclusive Diagnosed Peripheral Neuropathic Pain ( PNP ) since least 6 month Being affiliate national welfare system Are reliable willing make available duration study willing follow study procedure Have give write informed consent approve relevant Ethics Committee ( EC ) govern study site PNP disease diagnosis inclusion criterion : Patient chronic PNP support distinct neuroanatomical plausible distribution sensory sign symptom , consecutive one follow cause : traumatic event , surgical procedure ( exclude limb amputation ) , radiculopathy , postherpetic postzooster neuralgia , diabetic polyneuropathy postanticancer chemotherapy . Diagnosis confirm DN4 questionnaire screen visit ( pain consider neuropathic DN4 score â‰¥ 4 ) Pain present since least 6 month Patients require score 4 8 inclusive mean Average Pain Score ( APS ) Numeric Rating Scale ( NRS ) baseline period precede randomization ( data collect patient diary ) complete least 4 day pain assessment Pregnant , breastfeeding , willing pregnant within 2 month With current recent history , determine Investigator , severe , progressive , and/or uncontrolled renal , hepatic , hematological , gastrointestinal , endocrine , pulmonary , cardiac , neurological , cerebral disease would interfere patient 's participation study Uncontrolled epilepsy Any current primary psychiatric condition , include major depression major personality disorder ( Axe II Diagnostic Statistical Manual Mental Disorders ( DSMIV ) ; personality disorder mental retardation ) Alcohol dependence regular use know drug abuse ( e.g. , amphetamine , barbiturate , benzodiazepine , cannabinoids , cocaine , methadone , opiates , phencyclidine ) Acute disease state within 7 day Visit 2 Any relevant medical disorder likely interfere trial represent risk patient Any close relationship Investigators Sponsor ( i.e . belong immediate family subordination link ) Patient legal protection , accord national law Patient currently enrol clinical trial involve use investigational drug device , concurrently enrol type medical research judge scientifically medically compatible study , exclusion period accord national law Exclusion criterion related PNP : Neuropathic pain due trigeminal neuralgia , central pain , complex regional pain syndrome phantom limb pain Plan session physiotherapy comportemental therapy gestion pain , hypnosis , sophrology , meditation program study Have initiate plan electrical stimulation ( neurostimulation ) therapy within 2 week prior Visit 1 study period Visit 5 Patient change his/her `` regular therapy `` last 4 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Pain</keyword>
</DOC>